Core Viewpoint - The article highlights the advancements and innovations in the production and application of hyaluronic acid by Huaxi Biological Technology Co., Ltd., showcasing its transition from a high-cost medical ingredient to a widely used component in various consumer products through technological breakthroughs [1][2][3]. Group 1: Technological Innovations - Huaxi Biological achieved a 90% reduction in production costs of hyaluronic acid through microbial fermentation, breaking international monopolies and enabling industrial-scale production [3]. - The introduction of enzyme cutting technology in 2011 allowed for precise control of molecular weight, leading to the development of products with different functionalities and earning national recognition [3]. - The adoption of synthetic biology technology in 2020 further enhanced production efficiency by three times and enabled zero-carbon production [3][5]. Group 2: Industry Position and Market Demand - Huaxi Biological has established a complete industrial chain from raw material development to end-user applications, positioning itself as a leader in the global hyaluronic acid market [5][7]. - The company has diversified its product offerings across four main business segments: raw materials, pharmaceuticals, skincare products, and functional foods, which collectively support its growth [7]. - The inclusion of sodium hyaluronate in the new food raw material directory by the National Health Commission in 2021 has spurred the development of new products like "Water Muscle Spring" hyaluronic acid drinking water [7]. Group 3: Global Expansion and Brand Development - Huaxi Biological is leveraging its innovative strategies to penetrate international markets, enhancing product competitiveness and brand recognition [7][8]. - The company is not only selling raw materials but also exporting standards and expanding its market presence in regions like Europe, Japan, and the United States [7]. - The growing global demand for health and wellness products, driven by aging populations, is facilitating the expansion of hyaluronic acid applications in everyday life [7][8].

为了增进公众对透明质酸的了解，并推动中国透明质酸产业的升级与发展，华熙生物在2023年首届中国（济南）透明质酸产业大会上联合多家行业单位，倡 议将每年的6月3日设立为"透明质酸健康日"。 从 " 标准制定 " 到 " 国际话语权构建 " 改写行业规则的中国力量 "透明质酸健康日"的倡导设立，背后藏着华熙生物在透明质酸产业领域的绝对话语权，同时也印证着华熙生物在透明质酸领域所取得的诸多突破性成就。 作为透明质酸行业龙头，华熙生物主导修订了欧洲药典、中国药典相关标准，并推动 5 项国家标准落地。2024年7月1日，由华熙生物主导修订的QB/T 4576- 2023《透明质酸钠》行业标准正式实施。这一新版标准取代了原有的QB/T 4576-2013版本，正式将"透明质酸"、"玻尿酸"等商品化名称纳入标准文件。作为 新标准的第一起草单位，华熙生物全程深度参与了该标准的立项、起草和验证的全过程。公司不仅修订了多项技术指标，更推动了专利技术——"高效液相 色谱法"（专利号：ZL201110202860.X）作为测定透明质酸钠含量的方法，首次被纳入行业标准。此项技术的标准化，进一步为透明质酸钠含量的量化测定 提供科学的操作 ...